CRIS Current Research Information System

DE PONTI, FABRIZIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.349
AS - Asia 12.617
EU - Europa 10.044
AF - Africa 814
SA - Sud America 733
OC - Oceania 39
Continente sconosciuto - Info sul continente non disponibili 37
Totale 38.633
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.158
SG - Singapore 3.448
VN - Vietnam 3.153
CN - Cina 2.934
IT - Italia 2.591
GB - Regno Unito 2.325
DE - Germania 1.191
HK - Hong Kong 1.140
SE - Svezia 771
IN - India 592
FR - Francia 553
UA - Ucraina 551
BR - Brasile 546
RU - Federazione Russa 498
IE - Irlanda 327
NL - Olanda 296
JP - Giappone 272
CI - Costa d'Avorio 227
TG - Togo 216
KR - Corea 201
FI - Finlandia 192
ZA - Sudafrica 184
BD - Bangladesh 177
EE - Estonia 144
CA - Canada 118
PH - Filippine 102
JO - Giordania 90
TH - Thailandia 86
BE - Belgio 81
CH - Svizzera 81
AR - Argentina 77
HR - Croazia 74
ID - Indonesia 74
BG - Bulgaria 73
AT - Austria 60
PL - Polonia 53
NG - Nigeria 49
SC - Seychelles 48
TW - Taiwan 48
TR - Turchia 43
SA - Arabia Saudita 41
MX - Messico 40
ES - Italia 39
IQ - Iraq 39
GR - Grecia 35
EU - Europa 34
AU - Australia 31
UZ - Uzbekistan 30
EC - Ecuador 29
PK - Pakistan 26
CO - Colombia 22
LT - Lituania 22
CL - Cile 20
RO - Romania 19
CZ - Repubblica Ceca 17
DZ - Algeria 15
EG - Egitto 15
IR - Iran 15
MY - Malesia 15
MA - Marocco 14
IL - Israele 12
KE - Kenya 12
LB - Libano 12
PE - Perù 12
PT - Portogallo 12
TN - Tunisia 11
VE - Venezuela 11
AZ - Azerbaigian 10
PY - Paraguay 10
AE - Emirati Arabi Uniti 9
JM - Giamaica 8
KZ - Kazakistan 8
NZ - Nuova Zelanda 8
SK - Slovacchia (Repubblica Slovacca) 7
AL - Albania 6
DK - Danimarca 6
GH - Ghana 6
HU - Ungheria 6
KG - Kirghizistan 5
BA - Bosnia-Erzegovina 4
CR - Costa Rica 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
NP - Nepal 4
OM - Oman 4
UY - Uruguay 4
HN - Honduras 3
KH - Cambogia 3
LK - Sri Lanka 3
MD - Moldavia 3
MN - Mongolia 3
NI - Nicaragua 3
PS - Palestinian Territory 3
SN - Senegal 3
SV - El Salvador 3
AM - Armenia 2
BO - Bolivia 2
BW - Botswana 2
CY - Cipro 2
GT - Guatemala 2
Totale 38.598
Salva come PNG Salva come JPEG
Città #
Singapore 2.356
Southend 2.005
Fairfield 1.279
Ashburn 1.271
Hong Kong 1.063
Chandler 939
San Jose 794
Ho Chi Minh City 671
Dong Ket 656
Wilmington 624
Woodbridge 574
Santa Clara 570
Seattle 562
Ann Arbor 543
Hanoi 529
Houston 496
Princeton 494
Hefei 453
Bologna 435
Cambridge 431
Beijing 415
Boardman 331
Dublin 318
Jacksonville 281
Los Angeles 281
Abidjan 227
Lauterbourg 220
Lomé 216
Tokyo 213
Council Bluffs 212
Westminster 187
Dallas 182
Padova 177
Nanjing 173
Milan 169
Seoul 162
New York 161
Helsinki 157
Berlin 150
Rome 148
Buffalo 135
Redmond 115
Saint Petersburg 102
Jinan 91
San Diego 91
Amman 88
Turin 83
Shanghai 82
São Paulo 81
Haiphong 78
Medford 76
Da Nang 75
Shenyang 73
Sofia 72
Bremen 71
Brussels 71
Florence 68
Frankfurt am Main 67
Guangzhou 66
The Dalles 64
Changsha 63
Redondo Beach 63
Nanchang 61
Hebei 60
Bern 58
Falls Church 58
Munich 58
Mülheim 58
London 52
Verona 51
Orem 50
Chicago 48
Tianjin 48
Toronto 47
Zhengzhou 47
Des Moines 44
Jiaxing 44
Bengaluru 43
Dearborn 43
Phoenix 43
Bangkok 42
Jakarta 39
Abeokuta 38
Vienna 34
Yubileyny 33
Shenzhen 32
Hangzhou 31
Mahé 31
Wuhan 31
Redwood City 30
Amsterdam 29
Nuremberg 29
Biên Hòa 28
Ningbo 28
San Francisco 28
Naples 27
Norwalk 27
Olalla 27
Falkenstein 26
Taipei 26
Totale 24.429
Salva come PNG Salva come JPEG
Nome #
Interazioni tra sistema serotoninergico e mediatori dell'infiammazione nella fisiopatologia della sindrome dell'intestino irritabile 787
Torsadogenic risk of antipsychotics: combining adverse event reports with drug utilization data across Europe. 492
Adverse events with sodium-glucose co-transporter-2 inhibitors: A global analysis of international spontaneous reporting systems 342
Adverse events with sacubitril/valsartan in the real world: emerging signals to target preventive strategies from the FDA adverse event reporting system 318
Escherichia coli Nissle 1917 restores epithelial permeability alterations induced by irritable bowel syndrome mediators 314
Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage 313
Adopting STOPP/START Criteria Version 3 in Clinical Practice: A Q&A Guide for Healthcare Professionals 307
Data Mining Techniques in Pharmacovigilance: Analysis of the Publicly Accessible FDA Adverse Event Reporting System (AERS) 303
Biomarkers of Kidney Injury in Very-low-birth-weight Preterm Infants: Influence of Maternal and Neonatal Factors 286
Adverse Events to Food Supplements Containing Red Yeast Rice: Comparative Analysis of FAERS and CAERS Reporting Systems 277
Adverse cardiovascular events associated with triptans and ergotamines for treatment of migraine: Systematic review of observational studies 272
Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System 269
Appropriateness of Proton Pump Inhibitor (PPI) prescription in patients admitted to hospital: Attitudes of general practitioners and hospital physicians in Italy 262
hERG-related drug toxicity and models for predicting hERG liability and QT prolongation 259
Colonic mucosal mediators from patients with irritable bowel syndrome excite enteric cholinergic motor neurons 259
Farmacologia. Azioni e Reazioni dei farmaci. 250
Switching among Equivalents in Chronic Cardiovascular Therapies: 'Real World' Data from Italy 247
Diagnosis and therapy of irritable bowel syndrome 242
Elementi di Farmacologia: Compendio per l’esame. 242
Antipsychotics and Torsadogenic Risk: Signals Emerging from the US FDA Adverse Event Reporting System Database. 242
Dipeptidyl peptidase-4 inhibitors and heart failure: Analysis of spontaneous reports submitted to the FDA Adverse Event Reporting System 238
Drug-Induced Renal Damage in Preterm Neonates: State of the Art and Methods for Early Detection 237
Nerve fiber outgrowth is increased in the intestinal mucosa of patients with irritable bowel syndrome 237
Pattern of drug use among preterm neonates: Results from an Italian neonatal intensive care unit 234
Advancements in drug development for diarrhea-predominant irritable bowel syndrome 232
beta3-adrenoceptors in the gut: evidence for a possible role in enteric neuroimmunomodulation 230
Amyotrophic Lateral Sclerosis as an Adverse Drug Reaction: A Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System 229
Impulse Control Disorders by Dopamine Partial Agonists: A Pharmacovigilance-Pharmacodynamic Assessment Through the FDA Adverse Event Reporting System 228
Altered Serotonin Signaling and Extrinsic Sensory Neuron Activation in Irritable Bowel Syndrome 227
Risk of hospitalization from drug-drug interactions in the Elderly: real-world evidence in a large administrative database 224
Severe quetiapine voluntary overdose successfully treated with a new hemoperfusion sorbent 223
Anticancer drugs and cardiotoxicity: Insights and perspectives in the era of targeted therapy. 222
Antibacterial macrolides: a drug class with a complex pharmacological profile 220
Predictors of antipsychotic prescription in a Northern Italian District (Bologna) 218
Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage. 215
Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome. 215
Prescriptions of antidepressants in primary care in Italy: pattern of use after admission of selective serotonin reuptake inhibitors for reimbursement 214
Animal models of chemically induced intestinal inflammation: Predictivity and ethical issues 212
Antimicrobials and the Risk of Torsades de Pointes. The Contribution from Data Mining of the US FDA Adverse Event Reporting System 211
Multiple sclerosis as an adverse drug reaction: clues from the FDA Adverse Event Reporting System 208
Long-acting injectable antipsychotics: Six-month follow-up of new outpatient treatments in Bologna Community Mental Health Centres 207
Non-peptidyl low molecular weight radical scavenger IAC attenuates DSS-induced colitis in rats. 202
Use of phytoestrogens and effects perceived by postmenopausal women: result of a questionnaire-based survey 199
Addition of dipeptidyl peptidase-4 inhibitors to sulphonylureas and risk of hypoglycaemia: systematic review and meta-analysis 198
Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System 197
Assessing liver injury associated with antimycotics: Concise literature review and clues from data mining of the FAERS database 196
Social and clinical descriptors of antipsychotic prescription 196
Use of antihistamines and risk of ventricular tachyarrhythmia: a nested case-control study in five European countries from the ARITMO project. 196
Crystal nephropathy and amoxicillin: insights from international spontaneous reporting systems 196
Myocarditis and pericarditis after immunization: Gaining insights through the Vaccine Adverse Event Reporting System 194
Posterior Reversible Encephalopathy Syndrome Associated With Licorice Consumption: A Case Report in a 10-Year-Old Boy 192
The Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO Project 192
Therapeutic innovation in the European Union: analysis of the drugs approved by the EMEA between 1995 and 2003. 189
Drug-induced Kounis syndrome: A matter of pharmacovigilance 189
An update on the first decade of the European centralized procedure: how many innovative drugs? 188
Neuroplasticity of the enteric nervous system induced by inflammatory conditions in the gut 188
Adverse events associated with the use of direct-acting oral anticoagulants in clinical practice: beyond bleeding complications 188
Human papillomavirus vaccine and demyelinating diseases-A systematic review and meta-analysis 188
Paraneoplastic Syndrome 185
Cardiovascular events in statin recipients: impact of adherence to treatment in a 3-year record linkage study 185
Clinically important drug-drug interactions in poly-treated elderly outpatients: A campaign to improve appropriateness in general practice 185
Occurrence of Multiple Sclerosis After Drug Exposure: Insights From Evidence Mapping 184
Ceftolozane/tazobactam exposure in critically ill patients undergoing continuous renal replacement therapy: a PK/PD approach to tailor dosing 184
Cyclin-dependent kinase 4/6 inhibitors and interstitial lung disease in the FDA adverse event reporting system: a pharmacovigilance assessment 183
Strategies and Tools for Supporting the Appropriateness of Drug Use in Older People 182
Review article: clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics 182
Disproportionality signal of progressive multifocal leukoencephalopathy: monoclonal antibodies versus other immunosuppressants 182
Drug-induced renal injury in neonates: challenges in clinical practice and perspectives in drug development 182
Aspetti clinici ed anticorpi anti-neurone nella malattia celiaca con disordini neurologici 181
Hepatitis B vaccination and the putative risk of central demyelinating diseases - A systematic review and meta-analysis 180
Pro-arrhythmic potential of oral antihistamines (H1): Combining adverse event reports with drug utilization data across Europe 180
Detection of D-penicillamine in skin lesions in a case of dermal elastosis after a previous long-term treatment for Wilson's disease 178
Case Report. 178
Evaluating sacubitril/valsartan as a treatment option for heart failure with reduced ejection fraction and preserved ejection fraction 177
5-HT7 Receptors Modulate Peristalsis and Accommodation in the Guinea Pig Ileum 176
Effects of the non-peptidyl low molecular weight radical scavenger IAC in DNBS-induced colitis in rats. 176
Exploring the underlying mechanisms of drug-induced impulse control disorders: a pharmacovigilance-pharmacodynamic study 175
Using artificial intelligence to create diverse and inclusive medical case vignettes for education 174
Protection from DNBS-induced colitis by the tachykinin NK1 receptor antagonist SR140333 in rats 174
Liver injury with drugs used for multiple sclerosis: A contemporary analysis of the FDA Adverse Event Reporting System 174
Dapagliflozin and cardiovascular outcomes: anything else to DECLARE? 173
QT interval shortening in spontaneous reports submitted to the FDA: the need for consensus 172
Enteric neuroplasticity evoked by inflammation 172
The hERG K+ channel: target and antitarget strategies in drug development. 171
Academic output from EU-funded health research projects 170
A clinical pharmacology and therapeutics teacher's guide to race-based medicine, inclusivity, and diversity 167
Mesenchymal stromal cell-based therapy: Regulatory and translational aspects in gastroenterology 166
Lessons to be Learnt from Real-World Studies on Immune-Related Adverse Events with Checkpoint Inhibitors: A Clinical Perspective from Pharmacovigilance 165
Delayed gastric emptying in functional dyspepsia 164
Antimicrobial-induced torsades de pointes: towards risk stratification by data mining of the FDA Adverse Event Reporting System. 164
La condivisione dei trattamenti farmacologici in psichiatria e la percezione degli effetti avversi ai farmaci antipisicotici da medico, paziente e familiare 163
Recurrence of pericarditis after influenza vaccination: a case report and review of the literature 162
Farmaci lassativi e purganti 161
Excipients in medicinal products used in gastroenterology as a possible cause of side effects. 159
Inflammatory neuropathies of the enteric nervous system 159
L'essenziale in Farmacologia Clinica 158
Fattori determinanti nell'utilizzo dei farmaci antipsicotici 158
Use and Perception of Phytoestrogens in Postmenopausal Women: Result of a Questionnaire-Based Survey 157
Targeting the arrhythmogenic substrate in atrial fibrillation: focus on structural remodeling 156
Macrolides and Torsadogenic Risk: Emerging Issues from the FDA Pharmacovigilance Database 156
Totale 21.482
Salva come PNG Salva come JPEG
Categoria #
all - tutte 108.998
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 108.998
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.006 0 0 0 0 0 0 0 0 0 0 0 1.006
2021/20224.483 556 147 257 225 361 275 185 276 176 228 1.084 713
2022/20234.512 446 555 300 564 309 314 211 286 764 194 388 181
2023/20241.573 129 218 141 167 151 239 67 116 54 113 105 73
2024/20255.333 296 866 619 296 843 319 349 202 142 316 172 913
2025/202613.039 955 1.093 1.206 844 1.429 761 1.724 405 2.424 1.014 742 442
Totale 39.381